Singapore study reveals variation in SARS-CoV-2 neutralizing antibody longevity

Scientists from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID) and the Agency for Science, ...

March 24, 2021 | Wednesday | News
Singapore develops AI platform to assess blood vessel anomalies

An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown Un...

March 24, 2021 | Wednesday | News
TrialWire launches StudyBoost, the Clinical trial insurance plan

TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...

March 23, 2021 | Tuesday | News
Healthtech startup Mesh Bio in Singapore raises $1.8 M in seed funding

Singapore-based healthtech startup Mesh Bio has raised $1.8 million (SGD2.4 million) in Seed funding, led by deep t...

March 23, 2021 | Tuesday | News
Singapore based firm Xylonix develops new immunity drug

Xylonix, a Singapore-based biotech company, has developed a new immunity drug (010DS-Zn) that demonstrates potential for...

March 22, 2021 | Monday | News
DocDoc, SpesNet to deliver world’s first completely digital health ecosystem

DocDoc Pte Ltd., the world’s first patient intelligence company based in Singapore, has partnered with SpesNet Glo...

November 20, 2020 | Friday | News
Singapore finds way to improve treatment outcomes for breast cancer

Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although...

March 19, 2021 | Friday | News
GenScript, G42 Healthcare provide innovative solutions to fight COVID-19

GenScript Biotech Singapore, a subsidiary of GenScript Biotech Corporation, a world leading biotechnology company and G4...

March 18, 2021 | Thursday | News
Singapore harnesses AI to identify cancer cells by examining pH level

Healthy and cancer cells can look similar under a microscope. One way of differentiating them is by examining the level ...

March 17, 2021 | Wednesday | News
Cytiva and Longitude reveal Healthcare industry challenges in Europe and Asia

Global life sciences leader Cytiva, along with the Financial Times’ research arm Longitude, have compiled a global...

March 16, 2021 | Tuesday | News
Singaporean POC TeleMedC forms R&D partnership with German UKE center through scaler8

TeleMedC, a Singaporean startup providing low-cost diagnostic solutions for point-of-care screening and virtual manageme...

March 16, 2021 | Tuesday | News
Singapore study signifies caregiving awareness to osteoporotic seniors

Singapore's researchers are involved in a study highlighting the urgency to involve caregivers of older adults...

March 11, 2021 | Thursday | News
Singapore identifies chemotherapy-resistant cancers’ escape mechanism

ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset ...

March 16, 2021 | Tuesday | News
Experts to discuss Senescent Cells role in female reproductive fitness

Singapore's NUS Yong Loo Lin School of Medicine (NUS Medicine) and Buck Institute’s Global Consortium for Reproduc...

March 15, 2021 | Monday | News
NTU reveals new study on autoimmune disorders and severe COVID-19

An overactive immune system leads to many autoimmune disorders – when the immune system mistakenly attacks healthy...

March 12, 2021 | Friday | News
Zuellig Pharma launches eZVax, a vaccine management solution

Zuellig Pharma, a leading healthcare services provider in Asia has launched eZVax, a vaccine management solution that en...

March 11, 2021 | Thursday | News
HSA approves first commercial CAR-T therapy by Novartis

Novartis has announced that Singapore Health Sciences Authority (HSA) has approved Kymriah (tisagenlecleucel) as th...

March 10, 2021 | Wednesday | News
A strong and balanced T Cell response prevents SARS CoV-2 infection

Even though they show no signs of COVID-19, people with asymptomatic infections mount a virus-specific T-cell immune res...

March 8, 2021 | Monday | News